Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
Like
Tweet
Print
Ole K. Kleist Jeppesen, n/a
Novo Nordisk A/S,
Novo Nordisk A/S, Denmark
Poster(s):
(P103) RELEVANCE OF BODY WEIGHT AND WEIGHT CHANGE ON CARDIOVASCULAR BENEFIT WITH SEMAGLUTIDE: A PRE-SPECIFIED ANALYSIS OF THE SELECT TRIAL
Friday, October 25, 2024
12:00 PM – 12:30 PM
PT